Clinical Trial Update: A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer [Phase 1]

View source ↗

Summary

This clinical trial update notes a Phase 1 study evaluating cemiplimab in combination with chemotherapy and immunotherapy for head and neck cancer, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Libtayo (cemiplimab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Cancer, Head Cancer | Phase 1 | Status: RECRUITING